Handbook of Experimental Pharmacology / Principles and Treatment of Lipoprotein Disorders

XXIII, 502 Seiten
1994
Springer Berlin (Hersteller)
978-3-540-57121-6 (ISBN)

Lese- und Medienproben

348,70 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken

Covering recent advances in the treatment of hyperlipidaemia, this volume explores the molecular mechanisms of the disease aetiology of arteriosclerosis in relation to major risk factors, dietary treatment of the disease, the treatment of associated diseases and the use of hypolipidaemic drugs.

Major advances have been made in the understanding of the molecular mechanisms of atherosclerosis, the disease that still affects more than 50 percent of the population in highly industrialized countries. This volume covers the most recent advances in the treatment of hyperlipidaemia. It represents a necessary update because molecular mechanisms of atherogenesis have been discovered in the past few years and their molecular mechanisms of action identified. Extensively treated are the molecular mechanisms of the disease etiology of arteriosclerosis in relation to the major risk factor 'hyperlipidaemia', rationale for more effective treatment of this disease by dietary means, the treatment of associated diseases, and the treatment using hypolipidaemic drugs.
Reihe/Serie Handbook of Experimental Pharmacology ; Vol.109
Zusatzinfo 75 figs., 68 tabs.
Sprache englisch
Gewicht 996 g
Einbandart gebunden
Schlagworte Arteriosklerose • Arteriosklerose / Arterienverkalkung • Handbook of Experimental Pharmacology; Vol 109 • Hyperlipidämie • Pharmakologie
ISBN-10 3-540-57121-3 / 3540571213
ISBN-13 978-3-540-57121-6 / 9783540571216
Zustand Neuware
Haben Sie eine Frage zum Produkt?